Broad evidence of xylazine in the UK illicit drug market beyond heroin supplies: Triangulating from toxicology, drug-testing and law enforcement

C. S. COPELAND ; K. RICE ; K. L. ROCK ; S. HUDSON ; P. STREETE ; A. J. LAWSON ; L. COUCHMAN ; A. HOLLAND ; S. MORLEY | 2024
Dans Addiction (Vol.119, n°7, July 2024) Article : Périodique

BACKGROUND AND AIMS: Xylazine is a non-opioid sedative which has spread rapidly throughout the US illicit drug supply. This study aimed to describe the spread of xylazine throughout the UK illicit drug supply. METHODS: Xylazine detections in h[...]

Plus d'info

Ajouter à la sélection

Lien externe

A deadly trend in fentanyl fatalities (England, 1998-2017)

H. CLARIDGE ; B. D. WILLIAMS ; C. S. COPELAND | 2020
Dans British Journal of Clinical Pharmacology (Vol.86, n°3, March 2020) Article : Périodique

Aim: To identify trends in drug-related deaths associated with fentanyl and its derivatives, including novel variants, in England, 1998-2017. Methods: Case reports from the National Programme on Substance Abuse Deaths (NPSAD) where a pharmaceut[...]

Plus d'info

Ajouter à la sélection